Conduct Disorder and Callous–Unemotional Traits in Youth — NEJM
Conduct Disorder and Callous–Unemotional Traits in Youth
R. James R. Blair, Ph.D., Ellen Leibenluft, M.D., and Daniel S. Pine, M.D.
- Article
- References
- Citing Articles (2)
- Glossary
- Letters
The term “conduct problems” refers to a pattern of repetitive rule-breaking behavior, aggression, and disregard for others. Such problems have received increased attention recently, owing to violent events perpetrated by youth and modifications in the
Diagnostic and Statistical Manual of Mental Disorders (DSM) criteria for conduct disorder, a syndrome involving recurrent conduct problems in children and adolescents. Youth conduct problems are predictive of an increased risk of substance abuse, criminal behavior, and educational disruption
1; they also incur a considerable societal burden from interpersonal suffering and financial costs.
2 This review summarizes current data on youth conduct problems and highlights promising avenues for research. Prior reviews have summarized either the clinical literature on outcome, treatment, and familial aggregation or the neurocognitive literature on mechanisms and pathophysiology.
3-5 The current review differs by more tightly integrating clinical and neurocognitive perspectives.
PSYCHOPATHIC TRAITS
Current research on conduct problems focuses heavily on psychopathic traits, labeled as “callous–unemotional” when referring to such traits in youth, which include reduced guilt, callousness, uncaring behavior, and reduced empathy. On the basis of this research, callous–unemotional traits have been added to the fifth edition of the DSM (DSM-5) as a specifier for the diagnosis of conduct disorder. (Given concerns about the potentially stigmatizing nature of the term “callous–unemotional,” this entity is instead indicated by the phrase “with limited prosocial emotions” in DSM-5.)
The addition of this specifier reflects efforts to identify syndromes characterized by combinations of clinical and neurocognitive features.
Callous–unemotional traits, which occur in fewer than half of young persons with conduct disorder, identify a subgroup with distinctive clinical features and neurocognitive perturbations. As compared with youth with conduct disorder who show remorse, empathy, and concern about school performance, those with callous–unemotional traits have a poorer prognosis and treatment response. 3,6,7 The current review contrasts research on these two subgroups to illustrate how combining clinical and neurocognitive perspectives might facilitate outcome prediction and the development of new therapeutics.
DEVELOPMENT AND OUTCOME
Most longitudinal research on conduct problems charts clinical profiles without concomitant data on neurocognitive functions. This work shows considerable heterogeneity in course: children with similar clinical profiles often have distinct longitudinal outcomes. Although some studies have begun to combine clinical and neurocognitive data in an attempt to predict outcome,
8-10 future prospective studies might do so more extensively, testing whether specific combinations of clinical and neurocognitive profiles identify subgroups with homogeneous outcomes.
For children with long-term behavioral problems, signs of conduct disorder often arise by early school age, but few children meet the full criteria for the disorder before 10 years of age. These early signs involve aggressive tendencies, impulsivity, and failure to comply with requests, which are features of attention deficit–hyperactivity disorder (ADHD) and oppositional–defiant disorder (see the Glossary). Prospective data show a trajectory of behavioral problems, with progression from ADHD in early school years to oppositional–defiant disorder in subsequent years, followed by conduct disorder as children approach adolescence.11 Although this developmental pattern is common, it is not typical in children who have early behavioral problems — that is, conduct disorder does not develop in most children with ADHD or oppositional–defiant disorder,12,13 and successful treatment of these two conditions may reduce the risk of progression. Like ADHD and oppositional–defiant disorder, callous–unemotional traits are expressed early. Such traits have been identified in children as young as 2 years of age,
14 and among young children with conduct problems, they predict a particularly early onset of a severe,
15 persistent variant of conduct problems.
7 Once the diagnosis of conduct disorder is established, the prognosis is usually considered to be poor, though the outcome varies. Antisocial personality disorder, which has a particularly poor prognosis, develops in slightly less than 50% of patients with conduct disorder; however, youth with conduct disorder in whom antisocial personality disorder does not develop typically have other long-term problems. Thus, persistent psychopathology is the rule, though its nature can vary.
16Considerable stability is seen in callous–unemotional traits, with stability coefficients of 0.5 to 0.7 among children followed over a period of 4 to 9 years.
4 The outcome may be particularly poor if the behavioral problems begin before 10 years of age.
17 Some research suggests that such an early onset predicts stronger biologic correlates and greater persistence into adulthood than the later-onset variant.
17 However, research has not consistently shown such distinctions for biologic features
18 or outcome.
19NEUROCOGNITIVE DYSFUNCTIONS
Promising work on outcome prediction and new therapeutics uses a neuroscientific systems approach, linking individual differences in behavior to underlying mechanisms that shape brain function. This approach is used in the Research Domain Criteria project (
www.nimh.nih.gov/research-priorities/rdoc/index.shtml). Fundamentally, the purpose of the project is to identify neurocognitive functions, for which the brain mechanisms are understood, that can predict outcome or treatment response. This approach requires research conducted at both a brain-systems level, focused on neural circuits, and a clinical level, focused on individual differences in behavior contributing to mental illness.
As described below, three neurocognitive dysfunctions have been linked to clinical aspects of conduct disorder, thereby bridging brain-systems and clinical data. This work has involved a range of clinical entities, which often overlap in patterns depicted in
Figure 1FIGURE 1
Overlap among Six Clinical Entities.. As discussed below, these dysfunctions are more clearly associated with callous–unemotional traits than the other entities shown in
Figure 1. Thus, the first dysfunction, deficient empathy, occurs relatively selectively in youth with these traits, whereas the second dysfunction, heightened threat sensitivity, does not occur in this group. Rather, heightened threat sensitivity occurs in patients who have conduct disorder without callous–unemotional traits and in patients with anxiety disorders. The third dysfunction, deficient decision making, is expressed similarly in youth with conduct disorder who have callous–unemotional traits and those without such traits. Moreover, deficient decision making may represent the lowest common denominator for conduct problems — that is, the dysfunction is shared by multiple syndromes involving conduct problems. Few studies have examined correlations among these three neural dysfunctions, and none have directly compared patterns of dysfunction in children with the different clinical presentations depicted in
Figure 1. Hence, it remains unclear how these dysfunctions interact to shape clinical profiles for individual children.
The hope is that further research on these three dysfunctions will generate biologically based diagnostic tests that are analogous to other diagnostic tests in medicine. That is, such tests would augment rather than replace current psychiatric-assessment techniques by differentiating among patients with similar clinical presentations on the basis of the ability of the tests to predict a specific course or treatment sensitivity.
Deficient Empathy
Empathy influences behavior at many levels. Persons who have high levels of empathy for a victim, relative to those with low levels of empathy, may show lower levels of aggressive response and higher levels of altruism toward the victim.
20-22 Developmentally, empathy is critical for socialization. Caregivers typically respond to transgressions that harm others by focusing on the victim's distress.
23 Children learn to refrain from harming others in order to prevent these associated aversive feelings.
Deficient empathy shows a particularly selective association with conduct disorder accompanied by callous–unemotional traits.
3 This deficiency is manifested in patients' reports of minimal emotional responses and an impaired ability to recognize distress in peers
24,25 or respond physiologically to it.
26,27 In youth with conduct disorder, the presence of callous–unemotional traits predicts a poor response to typical socialization practices.
1Deficient empathy is related to amygdala dysfunction.
3 The amygdala plays a central role in aversive conditioning. Through this form of reinforcement learning, persons learn to respond with fear to a previously neutral action or object, after the action or object has been paired with the occurrence of an aversive event.
28 Indeed, amygdala responses during prototypical forms of reinforcement learning are reduced in persons with psychopathic traits.
29 Functional magnetic resonance imaging (fMRI) studies have shown that adolescents with callous–unemotional traits, as compared with adolescents without such traits, have reduced amygdala responses to images of faces with fearful expressions
30-32; these weaker responses are presumably due to deficient empathy. Such studies require participants to view a series of faces that vary in their emotional features; faces with fearful expressions preferentially engage the amygdala relative to other expressions (
Figure 2FIGURE 2
Functional MRI Study of Face Processing.).
Heightened Threat Sensitivity
The amygdala functions in multiple circuits to support diverse psychological abilities. Beyond its role in empathy, the amygdala functions in a circuit encompassing the brain stem, the prefrontal cortex, and the association cortex in the temporal lobe. Heightened responsiveness of this circuit may be associated with general difficulties in the processing of emotional expression and certain peripheral hemodynamic changes in various forms of developmental psychopathology.
33-35 Moreover, the amygdala is part of a circuit, encompassing the hypothalamus and periaqueductal gray matter, that mediates graded responses to threats
36: from freezing to flight to reactive aggression with increasing proximity of the threat.
37 Increased activity in this circuit, after exposure to threat, increases the probability of reactive aggression.
Figure 3FIGURE 3
Relationships among the Proximity of a Threat, the Activity in a Particular Neural Circuit, and the Behavioral Response to the Threat. depicts the functioning of this circuit, illustrating how threat proximity modulates activity and behavior.
Functioning in this circuit may differentiate subgroups of youth with conduct disorder. One subgroup has callous–unemotional traits and shows reduced amygdala function when performing tasks that engage either empathic responding or threat assessment. The subgroup without callous–unemotional traits exhibits a different pattern, with atypically elevated threat-circuitry responsiveness,
38 a hostile attributional bias,
39 and increased risks of anxiety and aggression in reaction to frustration or threat.
1 Indeed, patients with conduct problems who do not have callous–unemotional traits, much like patients with anxiety disorders,
40 show elevated amygdala responses to threat, as compared with responses in youth free of psychopathology.
32 The risk of reactive aggression may be highest when such heightened responses occur in tandem with impulsivity or other features of ADHD. This combination is a feature of many disorders, including intermittent explosive disorder, borderline personality disorder, and disruptive mood dysregulation disorder.
41-43 In short, youth with elevated amygdala responsiveness to threat might have different problems over time and different responses to treatment than youth with normal or reduced amygdala responsiveness.
Deficient Decision Making
Persons who fail to learn how to make choices that lead to rewards rather than punishments are at high risk for impulsivity, frustration, and reactive aggression. Patients with conduct disorder exhibit such difficulties when performing tasks that require flexible responses to changing task contingencies.
44-46Neuroscientific systems research shows that the striatum and ventromedial prefrontal cortex represent the value of an action and influence prediction-error signaling (
Figure 4FIGURE 4
Format of a Functional MRI Study of Decision Making and Brain-Activation Data as They Relate to Prediction-Error Signals in the Basal Ganglia.), functions that are critical for decision making.
47 This research requires the participant to learn to differentiate rewarding from punishing stimuli by pressing a button after exposure to one type of stimulus and not pressing the button after exposure to the other type of stimulus. In such research, the participant is said to appropriately represent value when the participant has learned the corresponding rewarding and punishing consequences that follow from either pressing or not pressing the button after exposure to each stimulus. Before learning these stimulus–response contingencies, the participant cannot represent value and hence cannot predict the occurrence of rewards and punishments. In this context, receipt of an unexpected reward elicits a brain response known as a positive prediction error, indicating that an event is more rewarding than expected. Conversely, failure to receive an expected reward elicits a response known as a negative prediction error, indicating that an event is less rewarding than expected. In such research, youth with conduct problems show deficits in negative-prediction-error signaling, manifested by deficient recruitment of the striatum and ventromedial prefrontal cortex.
44-46 Thus, deficient brain functioning may be associated with deficient decision making.
Perturbed decision making occurs more broadly than perturbed empathy or threat sensitivity. Decision-making impairments occur in youth who have conduct disorder with or without callous–unemotional traits,
44 in youth with ADHD or oppositional–defiant disorder,
48-50 and even in unaffected children of parents with conduct problems or drug addiction.
51 Thus, impaired decision making may be a substrate for various types of conduct problems that frequently coexist, including DSM diagnoses of conduct disorder, ADHD, oppositional–defiant disorder, and substance-use disorders.
GENETIC AND ENVIRONMENTAL RISKS
Genetic and environmental risks interact through their effects on brain function. These interactions are seen in behavioral research involving twins, adoptees, and families in natural experiments as well as in molecular research on genetic and epigenetic factors.
Genetic Risk
Considerable data from genetic epidemiologic studies have shown moderate-to-high heritability for clinical aspects of conduct problems, including aggression52 and callous–unemotional traits.53Other work in this area has suggested that performance on neurocognitive tasks related to empathy and decision making is also heritable. 54 These findings point to an avenue for future research that integrates a neuroscientific systems approach with genetic studies to elucidate how genetic factors shape clinical profiles through effects on neurocognitive function. However, because research in this area is only beginning, a consensus has not emerged on the most productive directions for investigation. Some work has linked specific genetic polymorphisms with individual differences in the circuitry mediating empathy and threat sensitivity.
55 However, much of this research has relied on candidate-gene approaches in relatively small samples, raising concern about type I errors.
55 Environmental Risk
Different aspects of the environment relate to conduct problems at distinct developmental phases. Some factors, such as maternal diet or smoking, represent prenatal risks, which affect the development of neural structures (e.g., the amygdala, striatum, and ventromedial prefrontal cortex) that are linked to conduct disorder and perturbed neurocognitive functions.
56-58 Like research on genetic factors, this work suggests that environmental risks confer a predisposition to conduct problems through effects on neurocognitive function. Risk factors with a postnatal effect include low levels of parental monitoring, exposure to violence, and harsh and inconsistent discipline, as well as circumstances, such as poverty, in which the other risk factors tend to coalesce. As with prenatal risks, the later-occurring risks are also related to perturbed neurocognitive function.
Environmental factors may interact with characteristics of the child. For example, parenting variables have less effect on the conduct problems of children with callous–unemotional traits than on those of children without these traits.
59 In addition, the low degree of stress reactivity seen in youth with callous–unemotional traits may reduce the negative effects of exposure to adversities that predict heightened amygdala responses to threat,
60,61 anxiety,
62 and reactive aggression.
39TREATMENT
Various treatments reduce conduct problems. When delivered early, they can be effective
63,64 and may prevent developmental progression.
65 However, there is a need for better treatments. Currently available treatments target symptoms rather than underlying mechanisms, since the latter are, as yet, unknown. Most important, currently available treatments are only moderately effective.The hope is that pathophysiological research will yield more effective treatments. From this perspective, unique subgroups may exhibit unique dysfunctions in neural circuits that respond to specific treatments targeting these dysfunctions. Modest effectiveness in treating a heterogeneous construct such as conduct disorder may reflect the failure to tailor treatments to specific pathogenic mechanisms.
Two types of psychosocial intervention are effective in reducing conduct problems. One targets diverse behaviors with the use of multiple treatment components, including components that rely on principles from cognitive behavioral therapy to address anxiety and related emotional problems.Such problems can be viewed as clinical manifestations of threat-circuit hypersensitivity that occur in conduct disorder accompanied by anxiety and a hostile attributional bias. For example, Multidimensional Treatment Foster Care
66 and Multisystemic Therapy
67 treat diverse aspects of conduct problems by applying social and emotional learning techniques. In the treatment of anxiety, this involves the use of techniques from cognitive behavioral therapy. The therapist begins by having the child hierarchically rank the scenarios that elicit fear and by teaching the child strategies to minimize such fear. Next, the child works with the therapist to confront these scenarios and extinguish the associated fear, working gradually over time to confront increasingly frightening scenarios in each therapy session. These techniques may reduce reactive aggression by decreasing clinical anxiety, threat hypersensitivity, and associated cognitive perturbations, such as a hostile attributional bias.
The other form of effective psychosocial intervention facilitates proper child-rearing practices. This involves teaching parents to reduce stress in the home, use supportive rather than harsh limit-setting practices, monitor the child's activities, and obtain services as needed. Most research on these two types of intervention shows that children with callous–unemotional traits have a less robust response than children without such traits,
68,69 possibly because the interventions fail to target relevant mechanisms in the former group.
Two pharmacologic interventions also show promise, but concerns about adverse effects should lead to judicious use.
70 First, antipsychotic medications reduce irritability and aggression in children.
70-72 The Food and Drug Administration (FDA) has approved two medications, risperidone and aripiprazole, for the treatment of irritability and aggression in autism. Although autism is not strongly associated with conduct problems, data leading to FDA approval for these indications broadly inform clinicians regarding the use of these agents in children. Other data show efficacy in youth conduct problems occurring in other contexts, but the usefulness of the drugs is limited by short-term adverse effects, such as sedation, and long-term adverse effects from disrupted metabolic and neurologic functions.
Second, data also show benefits of psychostimulant medications. For example, methylphenidate reduces aggression in youth with ADHD or with conduct disorder, even in the absence of ADHD.
73In general, psychostimulants are preferable to antipsychotic agents owing to fewer adverse effects.Nevertheless, stimulants can exacerbate anxiety and cause agitation. Moreover, as with antipsychotic agents, evidence of a benefit comes from short-term efficacy studies.
Although there has been minimal research on the long-term stability of brain dysfunction in conduct disorder, biologic markers assessed at one point in time have been shown to predict the long-term outcome.
8-10 This suggests that brain dysfunction associated with conduct disorder exhibits some degree of stability. Thus, although clinical experience suggests that signs and symptoms can wax and wane in children with behavioral problems, it is unusual for these problems to remit spontaneously in children with conduct disorder, necessitating long-term treatment. Clinical experience suggests that psychostimulants can be prescribed safely for relatively long periods of time with careful monitoring. However, even though no long-term risks of psychostimulants have been unequivocally documented, concerns remain about growth disruption, adverse cardiovascular effects, and adverse effects on behavior, such as substance abuse; more research is needed on these possible effects.
FUTURE DIRECTIONS AND CONCLUSIONS
Current research seeks to identify new treatment approaches that are based on knowledge of pathophysiology and to use this knowledge to tailor treatments to individual patients. There is relatively good evidence of dysfunctional mechanisms, at least at the neuroscientific systems level, that are linked to conduct disorder. The critical test will be whether this information can be used to predict the course of the disorder and identify treatment for individual patients. Given the state of the research, this will require many years. Nevertheless, preliminary findings suggest that measures reflecting the integrity of threat-related or decision-making circuitry might predict risk.
8-10Currently, there are virtually no data on biomarkers that might be used to predict the response to treatment, and there are only limited data on the ways in which current treatments alter pathophysiology.In conclusion, the diagnosis of conduct disorder encompasses at least two subgroups: one group exhibits callous–unemotional traits, which are associated with an increased risk of persistent antisocial behavior; the other group shows heightened threat sensitivity and reactive aggression. Both groups have perturbations in neural systems that are critical for decision making. Conduct disorder with callous–unemotional traits appears to be more difficult to treat, and advances in our understanding of the pathophysiology of this type of conduct disorder may aid in the search for new treatments.
Disclosure forms provided by the authors are available with the full text of this article at NEJM.org.
No potential conflict of interest relevant to this article was reported.
SOURCE INFORMATION
From the National Institute of Mental Health Intramural Research Program, National Institutes of Health, Bethesda, MD.
Address reprint requests to Dr. Blair at the National Institute of Mental Health, National Institutes of Health, 10 Center Dr., Rm. 4C104, Bethesda, MD 20892-1366, or at
jamesblair@mail.nih.gov.
.png)
No hay comentarios:
Publicar un comentario